A detailed history of Revelation Capital Management, LLC transactions in Neuro Pace Inc stock. As of the latest transaction made, Revelation Capital Management, LLC holds 42,972 shares of NPCE stock, worth $274,161. This represents 3.78% of its overall portfolio holdings.

Number of Shares
42,972
Previous 248,127 82.68%
Holding current value
$274,161
Previous $1.23 Million 86.89%
% of portfolio
3.78%
Previous 17.38%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 07, 2022

SELL
$3.1 - $5.98 $635,980 - $1.23 Million
-205,155 Reduced 82.68%
42,972 $161,000
Q2 2022

Aug 15, 2022

SELL
$4.95 - $8.7 $656,261 - $1.15 Million
-132,578 Reduced 34.82%
248,127 $1.23 Million
Q1 2022

May 12, 2022

SELL
$7.06 - $11.57 $2.02 Million - $3.31 Million
-285,835 Reduced 42.88%
380,705 $3.13 Million
Q4 2021

Feb 14, 2022

BUY
$8.63 - $17.36 $5.75 Million - $11.6 Million
666,540 New
666,540 $6.72 Million

Others Institutions Holding NPCE

About NeuroPace Inc


  • Ticker NPCE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,846,900
  • Market Cap $159M
  • Description
  • NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...
More about NPCE
Track This Portfolio

Track Revelation Capital Management, LLC Portfolio

Follow Revelation Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Revelation Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Revelation Capital Management, LLC with notifications on news.